243 related articles for article (PubMed ID: 24113443)
1. [Association between multiple myeloma and acute myeloid leukemia secondary to myelodysplastic syndrome].
Jennane S; Eddou H; Mahtat el M; Konopacki J; Souleau B; Malfuson JV; Foissaud V; de Revel T
Ann Biol Clin (Paris); 2013; 71(5):581-4. PubMed ID: 24113443
[TBL] [Abstract][Full Text] [Related]
2. [Simultaneous occurrence of acute myeloid leukemia with multilineage dysplasia and multiple myeloma].
Yanagimoto M; Usuki K; Iijima K; Hirai Y; Iki S; Urabe A
Rinsho Ketsueki; 2003 Jan; 44(1):19-24. PubMed ID: 12649833
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndrome with del (5q) and JAK2(V617F) mutation transformed to acute myeloid leukaemia with complex karyotype.
Pich A; Godio L; Riera L; Cavaliere C; Kerim S; Bonello L; Francia di Celle P
Ann Hematol; 2016 Feb; 95(3):525-7. PubMed ID: 26750119
[No Abstract] [Full Text] [Related]
4. Case report of isochromosome 17q in acute myeloid leukemia with myelodysplasia-related changes after treatment with a hypomethylating agent.
Sousa JC; Germano RT; Castro CC; Magalhaes SM; Pinheiro RF
Genet Mol Res; 2012 Aug; 11(3):2045-50. PubMed ID: 22911588
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous occurrence of the 5q- syndrome and multiple myeloma.
Rios R; Sole F; Gascon F
Clin Lab Haematol; 2000 Feb; 22(1):49-53. PubMed ID: 10762305
[TBL] [Abstract][Full Text] [Related]
6. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
[TBL] [Abstract][Full Text] [Related]
7. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
8. Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis.
Patel LM; Maghari A; Schwartz RA; Kapila R; Morgan AJ; Lambert WC
Int J Dermatol; 2012 Apr; 51(4):383-8. PubMed ID: 22435424
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma.
Rödjer S; Swolin B; Weinfeld A; Westin J
Cancer Genet Cytogenet; 1990 Aug; 48(1):67-73. PubMed ID: 2372790
[TBL] [Abstract][Full Text] [Related]
10. Disappearing myelodysplastic syndrome-associated hemolytic anemia in leukemic transformation.
Tabata R; Tabata C; Omori K; Nagai T
Int Arch Allergy Immunol; 2010; 152(4):407-12. PubMed ID: 20197683
[TBL] [Abstract][Full Text] [Related]
11. More on polymyalgia rheumatica (PMR) as a paraneoplastic rheumatic syndrome in the elderly (bicytopenia and PMR preceding acute myeloid leukemia).
Anton E
J Clin Rheumatol; 2007 Apr; 13(2):114. PubMed ID: 17414547
[No Abstract] [Full Text] [Related]
12. [Myelodysplastic syndromes: multiplicity of the hematologic and clinical aspects].
Bernasconi C; Lazzarino M; Morra E; Alessandrino EP; Brusamolino E; Bernasconi P; Inverardi D
Haematologica; 1989 Oct; 74(5 Suppl):110-27. PubMed ID: 2512202
[No Abstract] [Full Text] [Related]
13. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia.
Bresolin S; Trentin L; Zecca M; Giordan M; Sainati L; Locatelli F; Basso G; te Kronnie G
Leukemia; 2012 Jul; 26(7):1717-9. PubMed ID: 22411123
[No Abstract] [Full Text] [Related]
15. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
[TBL] [Abstract][Full Text] [Related]
16. Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).
Jarosova M; Nedomova R; Hubacek J; Holzerova M; Mickova P; Katrincsakova B; Pikalova Z; Papajik T; Indrak K
Leuk Res; 2012 Apr; 36(4):e68-70. PubMed ID: 22284693
[No Abstract] [Full Text] [Related]
17. Array CGH in human leukemia: from somatics to genetics.
van der Veken LT; Buijs A
Cytogenet Genome Res; 2011; 135(3-4):260-70. PubMed ID: 21893961
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.
Kim YG; Cho SY; Park TS; Oh SH; Yoon HJ
Ann Clin Lab Sci; 2011; 41(1):79-83. PubMed ID: 21325260
[TBL] [Abstract][Full Text] [Related]
19. Clonal evolution in primary 5q-syndrome.
Wong KF; Chan JK; Chu YC; Kwong YL
Cancer; 1992 Jul; 70(1):100-3. PubMed ID: 1606529
[TBL] [Abstract][Full Text] [Related]
20. NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
Forghieri F; Paolini A; Morselli M; Bigliardi S; Bonacorsi G; Leonardi G; Coluccio V; Maccaferri M; Fantuzzi V; Faglioni L; Colaci E; Soci F; Nasillo V; Messerotti A; Arletti L; Pioli V; Zucchini P; Quadrelli C; Corradini G; Giacobbi F; Vallerini D; Riva G; Barozzi P; Lagreca I; Marasca R; Narni F; Mecucci C; Ottaviani E; Martinelli G; Falini B; Luppi M; Potenza L
Leuk Lymphoma; 2015; 56(11):3222-6. PubMed ID: 25813079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
